Rockwell Medical Technologies (RMTI) Misses Q2 EPS by 1c

Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.86 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• BofA says investors are increasingly worried about an AI boom-bust cycle
• RMX Industries signs GPU purchase order with Technologent